Millennium Management
LABU icon

Millennium Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Millennium Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,784
Closed -$780K – 7303
2022
Q2 		$780K Buy
+5,784
New +$985K ﹤0.01% 4600
2020
Q4 		– Sell
-228
Closed -$245 – 5410
2020
Q3 		$245 Buy
+228
New +$261K ﹤0.01% 3969

Other funds holding LABU

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

Millennium Management's LABU Position: Q3 2022 in Review

Millennium Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2022, closing a stake of 5,784 shares — an estimated $780K sold.

Millennium Management first reported a position in LABU in Q3 2020 and held it in 2 quarters. The position peaked at $780K in Q2 2022. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2022.

  • Millennium Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
  • Millennium Management sold 5,784 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2022, an estimated $780K.
  • Millennium Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2020 and held it in 2 quarters.
  • Millennium Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $780K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.